Mylotarg gemtuzumab ozogamicin 5mg

Mylotarg gemtuzumab ozogamicin 5mg

The drug Mylotarg (gemtuzumab ozogamicin) - Mylotarg (gemtuzumab ozogamicin) has received FDA approval and can be used effectively for the treatment of acute myeloid leukemia. The drug is used in the complex targeted therapy of the disease. The medicine is manufactured by the renowned pharmaceutical company Pfizer. Description An effective antitumor drug is a conjugate of moloclonal antibodies to CD33 and an antibacterial substance calicheamicin. Available as a solution for intravenous injection. Means Milotarg (gemtuzumab ozogamicin) - Mylotarg (gemtuzumab ozogamicin) to buy a can of a below-market price.

  • Pfizer

Price: $ 7000


Side effects In some cases, the medicine causes: • headaches; • stool disorders; • nausea, vomiting; • insomnia; • depression; • neurological disorders; • dizziness; • jumps in blood pressure. A pronounced manifestation of adverse reactions requires consultation with your doctor. In some situations, fever and hypoxemia may develop. The drug is stored in a refrigerator at t 2-8 degrees. Do not freeze the vial with the medicinal composition. For the drug Mylotarg (gemtuzumab ozogamicin) - Mylotarg (gemtuzumab ozogamicin), the cost does not have extra markups.

Indications The drug is used for acute myeloid leukemia in adults and children with CD33 expression. Prescribed by a doctor. How does The drug components recognize the human CD33 antigen and inhibit tumor activity. Hydrolytic cleavage of the linker occurs under the action of the drug. The drug disrupts the reactions that contribute to the development of the disease and stops the abnormal cell cycle. The tool helps the patient to achieve complete remission of the disease and promotes the death of cancer cells. The tool improves the patient's well-being and eliminates the pronounced symptoms of the disease. Patient reviews are positive for the drug Mylotarg (gemtuzumab ozogamicin) - Mylotarg (gemtuzumab ozogamicin) . The high efficacy of this drug and a lesser manifestation of side reactions are noted. Application It is administered intravenously at an individual dosage calculated by the doctor. The agent can be used as monotherapy or in combination with Cytarabin and Daunorubicin. The dosage regimen depends on the characteristics and course of the disease. For the drug Mylotarg (gemtuzumab ozogamicin) - Mylotarg (gemtuzumab ozogamicin), the price in our store is lower than that of competitors, while we guarantee the quality of the medicine. Contraindications The medicine is not used in treatment for: • pregnancy; • lactation; • individual intolerance. During treatment, a woman should exclude the possibility of conceiving a child.

©2020 CopyRight All rights reserved.